Latest filing published 06 Mar 2020 for Aldeyra Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +15.6%Entry US$5.58 · Close at T+365 US$6.45
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David McMullin: trading record in brief
David McMullin discloses dealings in Aldeyra Therapeutics, Inc. to SEC (Form 4). In total, 3 filings cover trades dated from 5 September 2019 to 2 March 2020.
On the market, this insider has only ever bought: 1 purchase, €18k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants.
The newest entry dates from 6 March 2020: a share grant, in Aldeyra Therapeutics, Inc. The latest purchase dates back some time: it was published 2,618 days ago, on 9 September 2019. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David McMullin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 247,480 shares0Common StockSEC:0000899243-20-007447:0
- 250,000 shares0Common StockSEC:0000899243-20-007064:0
- 4,329 shares@ US$4.68100.0% of flowCommon StockSEC:0000899243-19-023128:0Canonical exit: 4 Dec 2019 (T+90)
3 of 3 declarations
